Published: 27 July 2021
Author(s): Massimo Radin, Silvia Grazietta Foddai, Irene Cecchi, Dario Roccatello, Savino Sciascia
Issue: October 2021
Section: Letter to the Editor

Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized by the presence of confirmed antiphospholipid antibodies (aPL) positive testing with thrombotic events potentially occurring at any level of the vascular bed [1] with a negative impact on the quality of life (QoL) [2].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.